Back to Journals » Cancer Management and Research » Volume 14
RETRACTED ARTICLE: Prognosis and Biological Function of miR-3195 in Non-Small Cell Lung Cancer
Authors Lu Y, Zhang X, Zhang H, Zhu Z
Received 21 October 2021
Accepted for publication 13 December 2021
Published 11 January 2022 Volume 2022:14 Pages 169—176
DOI https://doi.org/10.2147/CMAR.S345618
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Harikrishna Nakshatri
This paper has been retracted.
Lu Y, Zhang X, Zhang H, Zhu Z. Cancer Manag Res. 2022;14:169-176.
We, the Editors and Publisher of Cancer Management and Research, have retracted the following article.
Following publication of the article, concerns were raised about the duplication of images from Figure 4 with images from other unrelated articles. Specifically,
- An image from Figure 4B has been duplicated with an image for Figure 3F from Han X, Liu J, Liu Y, Mou L, Li C. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p. Cancer Manag Res. 2021;13:4393-440. https://doi.org/10.2147/CMAR.S305547.
The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.